Supported by five independent studies8,12–15,17, the TP53 noncoding variant (rs78378222[C]) increases glioma risk more significantly than for other tumors with an odds ratio (OR) ranging from 2.35 to 3.74 (Supplementary Table 1). This evidence concerns the gene TP53 and glioma.